Andrew Marshall
Principal investigator, leads HEALIONICS CORPORATION.
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$10.4MFederal grants as PI12 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
12 awards · $10.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 30, 2021 | NIH | SBIR Phase II Product and Regulatory Development of a Needle-Free Hemodialysis Access Port | $984K | HEALIONICS CORPORATION |
| Jun 25, 2020 | NIH | SBIR Phase II Product and Regulatory Development of a Needle-Free Hemodialysis Access Port | $998K | HEALIONICS CORPORATION |
| Sep 12, 2019 | NIH | SBIR Phase II Product and Regulatory Development of a Needle-Free Hemodialysis Access Port | $3.0M | HEALIONICS CORPORATION |
| Sep 1, 2019 | NIH | SBIR Phase I Infection Resistant Hemodialysis Access Graft | $225K | HEALIONICS CORPORATION |
| Sep 14, 2017 | NIH | SBIR Phase II Clinical Study of an Extended-Patency Dialysis Access Graft | $440K | HEALIONICS CORPORATION |
| Aug 7, 2017 | NIH | SBIR Phase II Biointegrating Dialysis Access Graft with Self Stabilizing Flow | $281K | HEALIONICS CORPORATION |
| Mar 22, 2017 | NIH | SBIR Phase II Infection and Thrombosis Resistant Needle-Free Hemodialysis Access Port and Graft Using STAR Biomaterials | $142K | HEALIONICS CORPORATION |
| Jul 21, 2016 | NIH | SBIR Phase II Biointegrating Dialysis Access Graft with Self Stabilizing Flow | $634K | HEALIONICS CORPORATION |
| Mar 31, 2016 | NIH | SBIR Phase II Infection and Thrombosis Resistant Needle-Free Hemodialysis Access Port and Graft Using STAR Biomaterials | $596K | HEALIONICS CORPORATION |
| Feb 22, 2016 | DoD | SBIR Phase II Biointegrated Synthetic Grafts for Reconstruction of Vascular Tissue | $1000K | HEALIONICS CORPORATION |
| Sep 10, 2015 | NIH | SBIR Phase II Biointegrating Dialysis Access Graft with Self Stabilizing Flow | $1.5M | HEALIONICS CORPORATION |
| Mar 9, 2015 | NIH | SBIR Phase II Infection and Thrombosis Resistant Needle-Free Hemodialysis Access Port and Graft Using STAR Biomaterials | $580K | HEALIONICS CORPORATION |
Peer ranks
Federal funding#70
Awards as PI#97
Patents#505
Companies
- HEALIONICS CORPORATIONLeads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.